Black Friday Sale - Ends Soon!
-35% Off Everything
ABT

Abbott Laboratories (ABT)

Last Price$118.8(0.2%)
Market Cap$196.2B
Intrinsic value score
3/10
Bad
Intrinsic value
$122.2
DCF value - $99.7 Relative value - $144.8
Undervalued
2.9%
LTM P/E
37.1x
Peer set median: 65.1x
Discount rate
7.7%

ABT Intrinsic value

ABT Intrinsic value overview

Sign up and unlock this exclusive content!
Sign Up for Free

ABT Historical intrinsic value

Sign up and unlock this exclusive content!
Sign Up for Free

ABT Relative value

ABT Valuation multiples overview

Crunching data... Almost there!

ABT vs Peer Set Valuation Multiples Dynamics

Crunching data... Almost there!

ABT DCF sensitivity

Crunching data... Almost there!

ABT Discount rate (WACC)

Crunching data... Almost there!

Discover more ABT fundamentals

Investing armour 2024
50+ visuals to equip yourself with investing wisdom. Sign up to receive it for FREE

FAQ

What is the DCF value of Abbott Laboratories (ABT)?

As of today, DCF Value of Abbott Laboratories is $99.7, which is overvalued by 15.6%, compared to the current market share price of $118.1

How was the DCF Value calculated?

Step 1: Calculating Intrinsic Enterprise Value DCF Value was calculated by estimating Abbott Laboratories future free cash flow and then discounting it, using a chosen discount rate to determine Intrinsic Enterprise Value of $74.4B Step 2: Balance Sheet Adjustments Intrinsic Equity Value is calculated by subtracting Balance Sheet items (Cash & Equivalents, Short-term investments and Total Debt) from previously calculated Intrinsic Enterprise Value. This Intrinsic Equity Value is then divided by the total number of outstanding shares of 1,734,455,938 to determine DCF Value of $99.7

What is the Relative value of Abbott Laboratories (ABT)?

As of today, Relative Value of Abbott Laboratories is $144.8, which is undervalued by 22.6%, compared to the current market share price of $118.1

How was the Relative Value calculated?

Relative Value was calculated by applying various valuation multiples (EV/Revenue, EV/EBITDA, P/E etc.) to Abbott Laboratories financials to determine Relative Value of $144.8

What is Abbott Laboratories (ABT) discount rate?

Abbott Laboratories current Cost of Equity is 8.1%, while its WACC stands at 7.7%. Cost of Equity is used to value equity, while discounting free cash flow to equity holders (such as Net Income or Free Cash Flow to Equity). Weighted Average Cost of Capital (WACC) is used to value the entire firm, while discounting cash flows available to both debt and equity holders (NOPAT or Free Cash Flow to the Firm)

How is Cost of Equity for Abbott Laboratories (ABT) calculated?

The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP). This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk. Cost of Equity = Risk-Free Rate + Beta x Effective Risk Premium (ERP) 8.1% = 4.52% + 0.7 x 5.0%

How is WACC for Abbott Laboratories (ABT) calculated?

WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations. The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure. WACC = Cost of Equity x Equity Weight in Total Capital + Cost of Debt x (1 - Effective Tax Rate) Debt Weight in Total Capital 7.7% = 8.1% x 92.1% + 3.9% x (1 - 21.7%) x 7.9%